Commonwealth Equity Services, LLC Adial Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

  • $63.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 29, 2021
BUY
$57.75 - $116.75 $427,985 - $865,234
7,411 Added 25.51%
36,461 $156,000
Q2 2021

Aug 11, 2021
BUY
$50.5 - $78.25 $353,500 - $547,750
7,000 Added 31.75%
29,050 $74,000
Q1 2021

May 04, 2021
BUY
$43.25 - $79.75 $493,698 - $910,346
11,415 Added 107.33%
22,050 $53,000
Q3 2019

Oct 30, 2019
BUY
$36.0 - $42.0 $382,860 - $446,670
10,635 New
10,635 $16,000

Others Institutions Holding ADIL

# of Institutions
1
Shares Held
5.5K
Call Options Held
0
Put Options Held
0
View Full List

About ADIAL PHARMACEUTICALS, INC.

ADIL Quotes by TradingView
  • Ticker ADIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,854,000
  • Market Cap $26M
  • Description
  • Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focu...
More about ADIL
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email